Alongside its development of artificial intelligence-powered software to analyze huge amounts of genomic, imaging and other healthcare data, Sophia Genetics is now turning to a new medium to explain that work to the masses.
The medtech this week launched a podcast called “Decoded,” in which founder and CEO Jurgi Camblong, Ph.D., will host expert guests for discussions aimed at unraveling how data, AI and other technologies can be used in diagnostics and precision medicine to solve major challenges in healthcare.
The podcast is meant to make insights into those approaches “radically accessible,” Ross Muken, Sophia’s president, said in a statement sent to Fierce Pharma Marketing.
“‘Decoded’ captures Jurgi’s visionary approach and his ability to engage with the most brilliant minds in science and technology, and make those conversations resonate far beyond the lab,” Muken said.
The first episode, for example, features Umberto Malapelle, Ph.D., chair of the predictive molecular pathology lab at the University of Naples Federico II. In the episode, “Liquid Biopsy Decoded,” Camblong and Malapelle talk about how the noninvasive molecular testing approach is advancing cancer care. Their discussion also aims to cut through the current generative AI hype to explain the types of AI software that are already being used more practically by hospitals and researchers.
The inaugural episode went live on Spotify, Apple Podcasts and Sophia’s website at the start of this week.
Episodes planned for later this year are slated to star guests from the likes of Microsoft and a major cancer center.
“In healthcare, too much knowledge remains trapped in silos—complex, inaccessible, and far from the people it’s meant to serve. With SOPHiA DDM, we’ve already helped clinicians analyze over 2 million patient profiles,” Camblong said in a statement, referencing the company’s data-driven medicine platform.
“Now, with ‘Decoded,’ I want to share that insight more broadly,” he continued. “These dialogues go beyond the hype. They make the science behind data, technology, and diagnostics understandable to patients, practitioners, and innovators alike. Because access to knowledge is the first step toward equity in healthcare.”